Updated: FDA places partial hold on BioNTech-MediLink ADC after multiple deaths
The FDA placed an early-stage BioNTech trial on partial clinical hold after researchers observed multiple deaths, the company said in an …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
